Direkt zum Inhalt
Merck
Alle Fotos(1)

Dokumente

T0800000

Theophyllin

European Pharmacopoeia (EP) Reference Standard

Synonym(e):

1,3-Dimethyl-xanthin, 2,6-Dihydroxy-1,3-dimethyl-purin, 3,7-Dihydro-1,3-dimethyl-1H-purin-2,6-dion

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C7H8N4O2
CAS-Nummer:
58-55-9
Molekulargewicht:
180.16
Beilstein:
13463
MDL-Nummer:
MFCD00079619
UNSPSC-Code:
41116107
PubChem Substanz-ID:
329826623
NACRES:
NA.24

Qualität

pharmaceutical primary standard

API-Familie

theophylline

Hersteller/Markenname

EDQM

Anwendung(en)

pharmaceutical (small molecule)

Format

neat

Lagertemp.

2-8°C

SMILES String

CN1C(=O)N(C)c2[nH]cnc2C1=O

InChI

1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)

InChIKey

ZFXYFBGIUFBOJW-UHFFFAOYSA-N

Angaben zum Gen

human ... ADORA1(134) , ADORA2A(135) , ADORA2B(136) , ADORA3(140) , PDE3A(5139) , PDE3B(5140) , PDE4A(5141) , PDE4B(5142) , PDE4C(5143) , PDE4D(5144)

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Allgemeine Beschreibung

Dieses Produkt wird, wie von der entsprechenden Pharmakopöe spezifiziert und geliefert, angeboten. Alle Informationen zu diesem Produkt, einschließlich SDB und jegliche Produktinformationen, wurden unter der Autorität der entsprechenden Pharmakopöe entwickelt und ausgestellt.
Weitere Informationen und Unterstützung finden Sie auf der Webseite der entsprechenden Pharmakopöe.

Anwendung

Theophylline EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Biochem./physiol. Wirkung

Phosphodiesterase Inhibitor; Diuretikum; Herzstimulant; Muskelrelaxans; Asthmamedikament.

Verpackung

Dieses Produkt wird, wie von der entsprechenden Pharmakopöe geliefert, angeboten. Die aktuellen Mengeneinheiten finden Sie im Referenzsubstanzen-Katalog der EDQM.

Sonstige Hinweise

Kann Verkaufsbeschränkungen unterliegen.

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

PHR1023

Theophyllin, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1151

Theophyllin, Pharmaceutical Secondary Standard; Certified Reference Material

1653004

Theophyllin, United States Pharmacopeia (USP) Reference Standard

1653117

Theophyllin-Schmelzpunktstandard, United States Pharmacopeia (USP) Reference Standard

1077708

8-Bromtheophyllin, United States Pharmacopeia (USP) Reference Standard

1653048

Theophyllin-verwandte Verbindung D, United States Pharmacopeia (USP) Reference Standard

1653037

Theophyllin-verwandte Verbindung C, United States Pharmacopeia (USP) Reference Standard

1653026

Theophyllin-verwandte Verbindung B, United States Pharmacopeia (USP) Reference Standard

1653060

Theophyllin-verwandte Verbindung F, United States Pharmacopeia (USP) Reference Standard

BP327

Theophyllin, British Pharmacopoeia (BP) Reference Standard

PHR2588

Theophyllin-verwandte Verbindung F, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2541

Theophyllin-verwandte Verbindung F, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2551

N-Methyl-5-(methylamino)-1H-imidazol-4-carboxamid -hydrochlorid, Pharmaceutical Secondary Standard; Certified Reference Material

1121038

8-Chlortheophyllin, United States Pharmacopeia (USP) Reference Standard

Piktogramme

Skull and crossbonesHealth hazard
GHS06,GHS08

Signalwort

Danger

H-Sätze

H301,H360D

Gefahreneinstufungen

Acute Tox. 3 Oral - Repr. 1B

Lagerklassenschlüssel

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 1

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Choose from one of the most recent versions:

Analysenzertifikate (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Kunden haben sich ebenfalls angesehen

Slide 1 of 1

1 of 1

Theobromin ≥98.0%

Sigma-Aldrich

T4500

Theobromin

Victoria Boswell-Smith et al.
The Journal of allergy and clinical immunology, 117(6), 1237-1243 (2006-06-06)
Theophylline has been relegated to a second- or even third-line therapy in the treatment of asthma and chronic obstructive pulmonary disease (COPD), behind glucocorticosteroids and beta2-agonists, although recent findings have suggested that theophylline possesses anti-inflammatory and immunomodulatory effects in addition
David J Henderson-Smart et al.
The Cochrane database of systematic reviews, (1)(1), CD000273-CD000273 (2010-01-22)
Recurrent apnea is common in preterm infants, particularly at very early gestational ages. These episodes of loss of effective breathing can lead to hypoxemia and bradycardia, which may be severe enough to require resuscitation including use of positive pressure ventilation.
Diego Caccavo et al.
Molecular pharmaceutics, 12(2), 474-483 (2014-12-17)
In this work the behavior of hydrogel-based matrices, the most widespread systems for oral controlled release of pharmaceuticals, has been mathematically described. In addition, the calculations of the model have been validated against a rich set of experimental data obtained
Laura López-Cruz et al.
Behavioural brain research, 270, 213-222 (2014-05-27)
Caffeine and theophylline are methylxanthines that are broadly consumed, sometimes at high doses, and act as minor psychostimulants. Both are nonselective adenosine antagonists for A1 and A2A receptors, which are colocalized with dopamine D1 and D2 receptors in striatal areas.
Bing Dai et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation, 60(3), 360-370 (2012-04-21)
Whether treatment with adenosine receptor antagonists such as theophylline can prevent contrast-induced acute kidney injury (AKI) remains controversial. We conducted a meta-analysis of randomized controlled trials using MEDLINE (1966 to July 2011), EMBASE (1980 to July 2011), Web of Science
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.